CiTherapeutics — Israeli Startup

About

Ci Therapeutics is a cannabis company dedicated to bringing advanced cannabis formulations to market. Its first product is focused on sleep disorders with a pipeline of additional products in development. The company is building a platform of formulations delivering advanced, clinically validated, unique formulations on pharmaceutical-grade delivery systems.

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is CiTherapeutics' primary focus?

CiTherapeutics is an Israeli cannabis company focused on bringing advanced cannabis formulations to market, with its initial product targeting sleep disorders.

When was CiTherapeutics founded?

CiTherapeutics was founded in May 2019.

What is the operational status of CiTherapeutics?

CiTherapeutics is currently inactive and ceased operations in May 2019.

Where is CiTherapeutics headquartered?

CiTherapeutics is headquartered in Bet Shemesh, Jerusalem District, Israel.

What is CiTherapeutics' current funding stage?

CiTherapeutics is in the Pre-Funding stage, with a total of $0 USD raised.

How many employees did CiTherapeutics have?

CiTherapeutics had between 1 and 10 employees, with an exact count of 6.

Who is a known founder of CiTherapeutics?

Saul Kaye is a founder of CiTherapeutics.

What are some of the products developed by CiTherapeutics?

CiTherapeutics developed products including nebican, Breeve, iCAN Sleep, and GasTrap Reactor.

What sector does CiTherapeutics primarily operate in?

CiTherapeutics primarily operates in the Health Tech & Life Sciences sector, specifically within Pharma & Medical Biotechnology and Medical Cannabis.

Sectors & technology

Primary sector

Health Tech & Life Sciences

Sub-sectors

Health Tech & Life SciencesPharma & Medical BiotechnologyMedical Cannabis

Technologies

BiologicalsHerbals

Target customers

Healthcare & Life SciencesLife SciencesPharmaceuticalsConsumersRecreational & LifestyleCannabis

Business model

B2B

CiTherapeutics — Full Company Profile (machine-readable)

Advanced Cannabis Formulations

About

Facts

Name	CiTherapeutics
Slug	citherapeutics
Type	Israeli Startup
Founded	2019
HQ city	Bet Shemesh
HQ country	IL
Primary sector	[object Object]
Sectors	[object Object], [object Object], [object Object]
Business models	B2B
Target customers	[object Object], [object Object], [object Object], [object Object], [object Object], [object Object]
Status	inactive
Current stage	Pre-Funding
Public stage	Pre-Funding
Total raised (USD)	0
Website	https://www.ci-therapeutics.com/
Crunchbase ID	ci-therapeutics
Israeli Companies Registrar	516024643

Team (1)

Name	Role	LinkedIn
Saul Kaye

Intelligence Q&A

What is CiTherapeutics' primary focus?

CiTherapeutics is an Israeli cannabis company focused on bringing advanced cannabis formulations to market, with its initial product targeting sleep disorders.

When was CiTherapeutics founded?

CiTherapeutics was founded in May 2019.

What is the operational status of CiTherapeutics?

CiTherapeutics is currently inactive and ceased operations in May 2019.

Where is CiTherapeutics headquartered?

CiTherapeutics is headquartered in Bet Shemesh, Jerusalem District, Israel.

What is CiTherapeutics' current funding stage?

CiTherapeutics is in the Pre-Funding stage, with a total of $0 USD raised.

How many employees did CiTherapeutics have?

CiTherapeutics had between 1 and 10 employees, with an exact count of 6.

Who is a known founder of CiTherapeutics?

Saul Kaye is a founder of CiTherapeutics.

What are some of the products developed by CiTherapeutics?

CiTherapeutics developed products including nebican, Breeve, iCAN Sleep, and GasTrap Reactor.

What sector does CiTherapeutics primarily operate in?

CiTherapeutics primarily operates in the Health Tech & Life Sciences sector, specifically within Pharma & Medical Biotechnology and Medical Cannabis.

About

Company Intelligence Q&A

Sectors & technology

Tags

Generate Slim Page